Thu. Jul 7th, 2022
COVID-19 treatment | DGCI rejects Dr Reddy’s application for full market authorisation for remdesivir: Report Dr Reddy’s proposal comes after the USFDA granted remdesivir full regulatory status – making it the first COVID-19 drug to receive full approval